Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

and RR (rifampicin-resistant) tuberculosis and should be a focus for case-finding efforts,” the authors wrote. Rifampicin is a key drug recommended by the World Health Organisation as first-line ...

Studies have found that children and teenagers treated for multidrug-resistant tuberculosis, including those in India, are under-represented in case numbers, with researchers calling for a "focus for ...

They found high rates of successful treatment (almost 90 per cent) in children and teenagers with extensively drug-resistant TB -- when the infection-causing bacteria is resistant to nearly all ...

Health officials in Kansas have reported a tuberculosis outbreak in the northeastern part of the state, with 67 active cases since 2024, marking one of the largest outbreaks in recorded history ...

A new clinical decision support system, "TBorNotTB," helps streamline airborne infection isolation decisions, reducing workload while maintaining TB detection accuracy. Study: TB or not TB?

A tuberculosis (TB) outbreak in the Kansas City area has gained national attention this week, with headlines claiming it’s the “largest outbreak in U.S. history” since the Centers for Disease Control ...

(A ketamine-derived drug called esketamine is approved for some people as part of treatment-resistant major depressive disorder in a certified clinical setting.) But doctors have developed a ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...